p11 (S100A10, annexin II light chain, calpactin I light chain) is a multifunctional protein that forms a heterotetrameric complex with Annexin A2, particularly at cell membranes. p11, alone or together with Annexin A2, interacts with several ion channels and receptors and regulates their cellular localization and function. Altered levels of p11 are implicated in the pathophysiology of several forms of cancer, psychiatric disorders, and neurodegeneration. Via interactions with ion channels and receptors, p11 modulates therapeutic actions of drugs targeting brain disorders. By serving as a plasminogen receptor, p11 plays an important role in plasmin generation, fibrinolysis, angiogenesis, tumor progression, and metastasis. Here, we review mechanisms whereby p11 regulates functions of ion channels and receptors in health and disease states.p11 Is a Widespread and Inducible S100 Member Protein p11 (also named S100A10, annexin II light chain, calpactin I light chain) was initially discovered as a binding partner to annexin A2 (AnxA2) [1]. p11 was subsequently found to be an S100 protein [2] belonging to a larger family of S100 proteins [3][4][5]. These are small (10-12 kDa) acidic proteins and constitute the largest subfamily of the EF-hand domain proteins [3][4][5]. They exist as symmetric homo-and heterodimers, with each monomer containing two calcium-binding EF-hand motifs. A unique feature of p11 is that it has mutations in both calcium-binding sites, making it calciuminsensitive [6]. p11 is widely distributed in the body and has been detected in the brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus [6]. Several different cell types, including endothelial cells, cardiomyocytes, ependymal cells, monocytes, T lymphocytes, and neurons, express high levels of p11 [7][8][9]. In the brain, p11 is mainly expressed in neurons [9], but also in reactive astrocytes of type A2, which protect against neurodegeneration [10]. The gene and protein levels of p11 are strongly inducible by various stimuli, including glucocorticoids, cytokines, growth factors, and neurotransmitters [7,11]. The promoter region of p11 includes several sites for transcription factors, including Sp1, βDRE, and GRE, which regulate its expression [7,12]. p11 expression is also regulated by methylation of its promoter [13,14]. As detailed later, aberrant changes of p11 expression have been found in multiple disease states, including several forms of cancer, psychiatric disorders, and neurodegeneration.
HighlightsThe level of p11 is altered in psychiatric and neurological disorders and in various forms of cancer.